FUP Stock Overview
Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
Fuji Pharma Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥9.15 |
| 52 Week High | JP¥12.60 |
| 52 Week Low | JP¥6.65 |
| Beta | 0.37 |
| 1 Month Change | -6.63% |
| 3 Month Change | -23.11% |
| 1 Year Change | 10.91% |
| 3 Year Change | 1.11% |
| 5 Year Change | -30.04% |
| Change since IPO | 394.59% |
Recent News & Updates
Recent updates
Shareholder Returns
| FUP | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -1.6% | 2.3% | 0.5% |
| 1Y | 10.9% | -28.6% | 1.3% |
Return vs Industry: FUP exceeded the German Pharmaceuticals industry which returned -28.2% over the past year.
Return vs Market: FUP exceeded the German Market which returned 2.3% over the past year.
Price Volatility
| FUP volatility | |
|---|---|
| FUP Average Weekly Movement | 5.8% |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: FUP's share price has been volatile over the past 3 months.
Volatility Over Time: FUP's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1965 | 1,621 | Takayuki Iwai | www.fujipharma.jp |
Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, as well as information regarding pharmaceuticals and health; and contract manufacturing services.
Fuji Pharma Co., Ltd. Fundamentals Summary
| FUP fundamental statistics | |
|---|---|
| Market cap | €224.70m |
| Earnings (TTM) | €30.31m |
| Revenue (TTM) | €249.41m |
7.4x
P/E Ratio0.9x
P/S RatioIs FUP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FUP income statement (TTM) | |
|---|---|
| Revenue | JP¥41.64b |
| Cost of Revenue | JP¥25.61b |
| Gross Profit | JP¥16.03b |
| Other Expenses | JP¥10.97b |
| Earnings | JP¥5.06b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
| Earnings per share (EPS) | 208.12 |
| Gross Margin | 38.51% |
| Net Profit Margin | 12.15% |
| Debt/Equity Ratio | 51.2% |
How did FUP perform over the long term?
See historical performance and comparison